MARLBOROUGH, Mass. -- Sunovion Pharmaceuticals Inc. (Sunovion) today announced that Latuda® (lurasidone HCl) tablets, a once-daily atypical antipsychotic agent indicated for the treatment of adult ...

As with other drugs, Latuda (lurasidone) can cause side effects, such as restlessness, nausea, and weight gain. If side effects of Latuda become difficult to tolerate, talk with your doctor or ...

Sunovion announced positive results from an extension study evaluating the long-term safety, tolerability and efficacy of Latuda (lurasidone HCI) as monotherapy or as an adjunct to lithium or ...

Latuda's (lurasidone HCI; Sunovion) expanded indication has been approved for pediatric patients aged 10 to 17 years who have major depressive episodes associated with bipolar I disorder. The Food and ...

Please provide your email address to receive an email when new articles are posted on . Sunovion recently announced positive phase 3 study findings for Latuda for bipolar I disorder depression in ...

Mark Iwicki’s top priority is driving the success of Latuda, an atypical antipsychotic for adults with schizophrenia. “It’s the most important product and business we have for the next couple of years ...

Please provide your email address to receive an email when new articles are posted on . To assess efficacy and safety of Latuda (lurasidone, Sunovion Pharmaceuticals) for schizophrenia in adolescents, ...

Latuda (lurasidone) is a prescription drug that’s prescribed to treat schizophrenia and bipolar disorder. Latuda comes as a tablet that you take by mouth. Latuda is prescribed to adults, adolescents, ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)-- Sunovion Pharmaceuticals Inc. (Sunovion) today announced that the U.S. Food and Drug Administration (FDA) has approved LATUDA ® (lurasidone HCl) tablets for the ...

Sunovion Pharmaceuticals' new antipsychotic drug has hit drugstores, aiming to capture a share of the already crowded market. It's a branded drug in a class that now includes one leading ...

The FDA has given the green light to Dainippon Sumitomo Pharma's Latuda (lurasidone), an atypical antipsychotic. The drug is designed to work like other atypcals such as Zyprexa, Risperdal or Seroquel ...